ChromaCode Non-Small-Cell Lung Cancer Assay

ChromaCode has launched a non-small-cell lung cancer (NSCLC) assay based on its High Definition PCR (HDPCR) technology for early-access customers. The assay panel detects actionable NSCLC variants in nine relevant genes using amplitude modulation and multi-spectral encoding. It requires low sample input, has reduced workflow complexity, cloud-based analysis, and can generate results in less than four hours.